Elanco Animal Health Hits New 52-Week High of $22.86

Elanco Animal Health, Inc. has reached a significant milestone by hitting a new 52-week high of USD 22.86 on October 30, 2025. This achievement underscores the company's strong performance in the Pharmaceuticals & Biotechnology sector, where it operates as a small-cap entity with a market capitalization of USD 9,464 million.
Over the past year, Elanco has demonstrated a robust performance, with a gain of 23.74%, outpacing the S&P 500's increase of 18.13%. The company's price-to-earnings (P/E) ratio stands at 14.00, indicating a competitive valuation within its industry. Additionally, Elanco maintains a debt-to-equity ratio of 0.54, reflecting a manageable level of debt relative to its equity.

Despite not offering a dividend yield, Elanco's return on equity is a noteworthy 7.26%, showcasing its ability to generate profits from shareholders' investments. The stock's previous 52-week low was recorded at USD 8.02, highlighting the significant upward movement in its price. This milestone reflects Elanco's ongoing efforts and position within the market.